Market Place
Sourcing Support
Gossamer Bio Announces Inducement Grant Under Nasdaq Rule 5635(c)(4)
07 Oct 2024 //
BUSINESSWIRE
Gossamer To Provide Seralutinib OLE Data At ATS 2024
14 May 2024 //
BUSINESSWIRE
Chiesi and Gossamer Bio collaborate to develop Seralutinib for PAH
06 May 2024 //
PR NEWSWIRE
Gossamer Bio to Host Webcast to Discuss Seralutinib Open-Label Extension Data
13 Dec 2023 //
BUSINESSWIRE
Gossamer Announces Seralutinib Meets Endpoint in PII TORREY Study in PAH
06 Dec 2022 //
BUSINESSWIRE
Gossamer touts phase 2 win but investors are wary
06 Dec 2022 //
FIERCEBIOTECH
Gossamer Bio Announces Second Quarter 2022 Financial Results
09 Aug 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.